CYP19A1 and deep vein thrombosis: According to recent research, the administration of tamoxifen, aromatase inhibitors, thalidomide, lenalidomide, bevacizumab, cisplatin, nitrogen mustard, or anthracycline has been linked to a higher incidence of DVT.1,26–41 These agents have been reported to initiate vascular injury by inducing apoptosis.